医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Inter Partner Assistance Hong Kong Ltd. Forms a Partnership With The CareVoice To Provide Fully Digital Health Journeys and Integrated Healthcare Solutions to the Hong Kong Health Insurance Market

2018年09月27日 AM10:05
このエントリーをはてなブックマークに追加


 

HONG KONG

Inter Partner Assistance Hong Kong Ltd. has partnered with The CareVoice to provide fully digital health journeys and integrated healthcare solutions to the insurance market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180926005325/en/

The fully digital and integrated health insurance customer journey. (Photo: Business Wire)

The fully digital and integrated health insurance customer journey. (Photo: Business Wire)

Inter Partner Assistance Hong Kong Ltd. maintains an extensive hospital network and has over 25 years of experience in managing IPMI claims and providing emergency assistance 24/7. Inter Partner Assistance Hong Kong Ltd. already provides claim adjudication and assistance services to a majority of the Health and Travel insurance companies in Hong Kong.

The CareVoice is an award-winning Shanghai based health InsurTech company which perfectly complements Inter Partner Assistance Hong Kong Ltd.’s footprint by adding a mobile-based and data-driven SaaS solution that digitalizes the healthcare and insurance journey with consumer’s interests first.

“We are confident that our partnership with The CareVoice will provide new advantages for our healthcare partners and continue to accelerate our healthcare innovations by providing end customers with a transparent, integrated and personalized healthcare experience.” said Joseph Lee, CEO of Inter Partner Assistance Hong Kong Ltd.

The CareVoice’s independent mobile SaaS platform breaks down barriers to bring easy healthcare navigation. Their unique platform also helps insurers to become true health partners to their customers by offering cutting edge innovations such as an AI voice-based Virtual Health Assistant for symptoms checker, powered by Sense.ly, with medical content originated from the Mayo Clinic.

The partnership focuses on the following areas to deliver value:

1. Empower insurance partners with cutting edge innovation for their customers.

  • Integrated platform adaptable to different environments (mobile app, web app, WeChat account) and operational in multiple languages.
  • Fully digitalized customer journey within one mobile experience.
  • Access to a voice-based Virtual Health Assistant powered by artificial intelligence.

2. Bring partners closer to their customers.

  • Clearly and precisely explain medical insurance benefits.
  • Engage with customers through personalized digital and health services.
  • Reward customers when being physically active and selecting high quality cost-effective medical providers.

3. Drive efficiency and lower operational costs.

  • Reduce unnecessary medical consultations by utilizing the Virtual Health Assistant’s symptom checker and triage.
  • Adopt a fully digitalized hotline and e-claims reimbursement process.
  • Receive actionable insights and data from anonymized customer usage behavior and post-claim surveys.

About Inter Partner Assistance Hong Kong Ltd.

Inter Partner Assistance Hong Kong Ltd. has specialized in providing assistance, travel and health services since 1992. With access to a Group proprietary network of 37 Alarm Centers and more than 6,500 correspondents worldwide, Inter Partner Assistance Hong Kong Ltd. has since demonstrated its ability to be instantly reactive and effective in all circumstances, anywhere in the world, 24 hours a day.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180926005325/en/

CONTACT

Inter Partner Assistance Hong Kong Ltd.
Joseph LEE,
CEO
T
+852 2851 0620
joseph.lee@ip-assistance.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • City of Hope and Imugene Announce First Patient Dosed in Phase 1 Trial to Test Cancer-Killing Oncolytic Virus Against Solid Tumors
  • 内布拉斯加大学医学中心和阿南达宣布,FDA批准了一项治疗创伤后应激障碍(PTSD)的研究性新药的临床试验
  • Emendo Biotherapeutics’ next generation CRISPR gene editing technologies achieve breakthrough results with allele-specific approach for ELANE-related Severe Congenital Neutropenia as presented at ASGCT Annual Meeting
  • Morinaga Milk Obtains the Registration of “New Food Ingredient” in China for Use of Its Probiotic Bifidobacterium longum BB536 in Infant and Toddler Foods
  • MSITEK Sponsors a Hospice IT and Digital Project in India as Part of CSR (Corporate Social Responsibility) Initiatives